World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
43657
World Ranking
4398
National Ranking
2402

Colin P. Dinney publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Colin P. Dinney sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 766 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Colin P. Dinney D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Colin P. Dinney sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Colin P. Dinney is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with significant work in surgery, molecular biology, oncology, urology, and pulmonary and respiratory medicine.

The scientist's research concentrates on several key areas, including bladder and urothelial cancer treatments, urinary and genital oncology studies, epigenetics and DNA methylation, urological disorders and treatments, cancer immunotherapy and biomarkers, cancer research and treatments, and esophageal cancer research and treatment.

Colin P. Dinney has contributed numerous papers across leading scientific venues. These include:

  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial (2020) in The Lancet Oncology
  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma (2020) in Nature Medicine
  • Assessment of Luminal and Basal Phenotypes in Bladder Cancer (2020) in Scientific Reports
  • Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design (2021) in The Journal of Urology
  • Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (2021) in European Urology Oncology

Their frequent co-authors include Ashish M. Kamat, Neema Navai, Kelly K. Bree, David J. McConkey, and Patrick J. Hensley, indicating a collaborative approach within the oncology and urology research communities.

Colin P. Dinney's works are often published in notable journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Journal of Clinical Oncology, European Urology, and British Journal of Urology. The scientist has a substantial number of publications in these high-impact venues, demonstrating consistent research activity in their fields of study.

Best Publications

  • Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

    Woonyoung Choi;Sima Porten;Seungchan Kim;Daniel Willis

  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

    Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

    Paul Perrotte;Takashi Matsumoto;Keiji Inoue;Hiroki Kuniyasu

  • miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

    Liana Adam;Meng Zhong;Woonyoung Choi;Wei Qi

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer

    Keiji Inoue;Joel W. Slaton;Beryl Y. Eve;Sun Jin Kim

  • Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma

    David A. Levy;Joel W. Slaton;David A. Swanson;Colin P.N. Dinney

  • Interferon-α-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule

    Joel W. Slaton;Paul Perrotte;Keiji Inoue;Colin P. N. Dinney

  • Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Jean Jacques Patard;Hyung L. Kim;John S. Lam;Frederick J. Dorey

  • Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice

    Robert A. Stephenson;Colin P. N. Dinney;Kazuo Gohji;Nelson G. Ordonez

  • Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.

    David J. McConkey;Woonyoung Choi;Lauren Marquis;Frances Martin

  • Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

    Jonathan C Nesbitt;Ernesto R Soltero;Colin P.N Dinney;Garrett L Walsh

  • Integrated therapy for locally advanced bladder cancer : final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

    Randall Millikan;Colin Dinney;David Swanson;Paul Sweeney

  • Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

    Colin P. N. Dinney;Diane R. Bielenberg;Paul Perrotte;Reuven Reich

  • Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

    Keiji Inoue;Joel W. Slaton;Paul Perrotte;Darren W. Davis

  • Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer

    Hushan Yang;Colin P. Dinney;Yuanqing Ye;Yong Zhu

  • Focus on bladder cancer

    Colin P.N. Dinney;David J. McConkey;Randall E. Millikan;Xifeng Wu

  • Clinical model of lifetime cost of treating bladder cancer and associated complications.

    Elenir B.C. Avritscher;Catherine D. Cooksley;H. Barton Grossman;Anita L. Sabichi

  • Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

    Vipulkumar Dadhania;Miao Zhang;Li Zhang;Jolanta Bondaruk

Frequent Co-Authors

Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Bogdan Czerniak
Bogdan Czerniak The University of Texas MD Anderson Cancer Center
David J. McConkey
David J. McConkey Johns Hopkins University
Wassim Kassouf
Wassim Kassouf McGill University
Xifeng Wu
Xifeng Wu Zhejiang University
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Seth P. Lerner
Seth P. Lerner Baylor College of Medicine
Surena F. Matin
Surena F. Matin The University of Texas MD Anderson Cancer Center
Jian Gu
Jian Gu The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are a range of flexible online degrees for students interested in Medicine, Healthcare Administration, or advanced nursing roles. For those considering a leadership path outside direct patient care, cahme-accredited online mha programs offer training in healthcare management and policy, preparing graduates for high-demand administrative roles.

Registered Nurses hoping to advance without the time commitment of clinical hours should explore the best online rn to bsn programs without clinical requirements. These programs are ideal for working RNs seeking career growth and higher pay while balancing existing responsibilities.

If you are looking to earn a doctoral-level qualification in nursing, dnp online programs can help you reach the highest levels of nursing practice in less time, with some programs offering accelerated paths to completion. For those concerned about tuition costs, there are also affordable dnp programs designed to make doctoral studies more accessible.

Exploring these pathways can open new opportunities in both clinical and non-clinical healthcare roles, whether you’re aiming for leadership, direct patient care, or academic positions.

Best Scientists Citing Colin P. Dinney

Trending Scientists

Recently Published Articles